NORMAN J CLEMENT RPH., DDS, NORMAN L.CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, IN THE SPIRIT OF WALTER R. CLEMENT BS., MS., MBA., BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC.T. SPIRIT OF REV. C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., WALTER F. WRENN III., MD., JULIE KILLINGWORTH, LESLY POMPY MD., CLINTON BATTLE, JR., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
Stanford Pain Relief Innovations Lab Speaker Series – Dr. Jennifer D. Oliva
FROM THE RICHARD “RED” LAWHERN PH.D. FILES
Monday, October 31, 2022
Hot Topics in Prescription Drug Surveillance: PDMPs & Ruan v. United States
THE DEA TARGETS HEALTHCARE PROVIDERS BASED ON SKIN COLOR AND NATION OF ORIGIN
Professor Oliva asserts:
” DEA’s Prescription Drug Monitoring Program (PDMP) predictive platforms deserve serious scrutiny because they are the only law enforcement-developed digital surveillance systems that health care providers have ever utilized to diagnose and treat patients. Providers may rely on unvalidated PDMP risk scores to make prescribing decisions because they view those scores as clinically useful.
That claim should be viewed with skepticism because there is no evidence that PDMP scores accurately ascertain patient drug misuse risk. It is also questionable whether clinical reliance on PDMP risk scores is truly voluntary, given that the regulatory environment leaves providers with little choice but to take seriously the information generated by proprietary PDMP algorithms.”
BRIEF OF AMICUS CURIAE PROFESSOR OF HEALTH LAW AND POLICY IN SUPPORT OF PETITIONER
Jennifer D. Oliva, JD
Dr. Jennifer D. Oliva is a Professor of Law at the University of California Hastings College of the Law, where her research and teaching interests include health law and policy, privacy law, evidence, torts, and complex litigation. Her scholarship has been published by or is forthcoming in, among other publications, the California Law Review, Duke Law Journal, Northwestern University Law Review, UCLA Law Review, North Carolina Law Review, Ohio State Law Journal, George Mason Law Review, and online companions to the University of Chicago and New York University law reviews. Professor Oliva is a United States Army veteran who serves as a Senior Scholar at Georgetown Law’s O’Neill Institute for National & Global Health Law and on the Science & Policy Advisory Council of the National Pain Advocacy Center. She is an honors graduate of Georgetown University Law Center, where she was a Public Interest Law Scholar and Executive Notes & Comments Editor of the Georgetown Law Journal. Before attending law school, Professor Oliva earned her master’s degree from the University of Oxford and her undergraduate degree from the United States Military Academy. While a cadet at West Point, she was selected for the Rhodes and Truman Scholarships.
FOR NOW, YOU ARE WITHIN